Details for Patent: 11,744,802
✉ Email this page to a colleague
Which drugs does patent 11,744,802 protect, and when does it expire?
Patent 11,744,802 protects BIKTARVY and is included in one NDA.
This patent has forty patent family members in twenty-nine countries.
Drugs Protected by US Patent 11,744,802
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gilead Sciences Inc | BIKTARVY | bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate | TABLET;ORAL | 210251-001 | Feb 7, 2018 | RX | Yes | Yes | 11,744,802 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,744,802
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 106645 | ⤷ Subscribe | |||
Australia | 2016354007 | ⤷ Subscribe | |||
Australia | 2020200995 | ⤷ Subscribe | |||
Brazil | 102016026127 | ⤷ Subscribe | |||
Canada | 2948021 | ⤷ Subscribe | |||
Chile | 2018001199 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |